Scale -

  • Revenue is 2080 Rs Cr; Annual Growth is 22 %; Continuous Growth over 3 years; in Top Quartile; 5 Year CAGR is 31 %
  • Ebitda is 614 Rs Cr; Annual Growth is 22 %; Continuous Growth over 3 years; in Top Quartile; 5 Year CAGR is 32 %
  • PBT is 75.14 Rs Cr; Annual Growth is 56 %; 5 Year CAGR is 45 %
  • PAT is 168 Rs Cr; Annual Growth is 52 %; Continuous Growth over 3 years; 5 Year CAGR is 40 %
  • Quarterly Revenue is 614 Rs Cr; Continuous Growth over 3 Quarters; in Top Quartile

Profitability -

  • PAT Margin is 8.08 %; Annual Growth is 25 %
  • Quarterly Profit margin is 9 %; Continuous Growth over 3 Quarters
  • PBDIT Margin is 29.51 %; in Top Quartile
  • Quarterly Ebitda Margin is 28 %; in Top Quartile

Return -

  • ROA is 3.37 %; Annual Growth is 48 %
  • ROE is 6.57 %; Annual Growth is 47 %; 5 Year CAGR is -22 %

Efficiency -

  • Operating cash flow is 519 Rs Cr; Annual Growth is 44 %; Continuous Growth over 3 years; in Top Quartile; 5 Year CAGR is 33 %
  • Quick Ratio is 1.04; Annual Decline is -30 %; Continuous Decline over 3 years
  • Current Ratio is 1.24; Continuous Decline over 3 years

Solvancy -

  • Debt/Equity is 0.08; Annual Decline is -38 %; Continuous Decline over 3 years; 5 Year CAGR is -51 %
  • Total Debt is 157 Rs Cr; Annual Decline is -36 %; Continuous Decline over 3 years
  • Long term Debt is 133 Rs Cr; Continuous Decline over 3 years
  • Contingent Liabilities is 164 Rs Cr; Continuous Growth over 3 years; 5 Year CAGR is 87 %

Quality -

  • Operating cashflow/PAT is 309 %; in Top Quartile; Continuous Decline over 3 years
  • Change in Inventories/Total Expenses is -1 %; in Bottom Quartile; Annual Growth is 31 %
  • Other Expenses/Total Expenses is 19 %; in Bottom Quartile; Continuous Growth over 3 years
  • Exceptional Items/PBT is 1 %; Annual Growth is 128 %; in Top Quartile
  • Current Tax/PAT is 48 %; Annual Growth is 35 %; Continuous Growth over 3 years; in Top Quartile

Quarterly Results- overall

Annual Results- Scale

Annual Results- Liquidity

Annual Results- Profitability/Return

Annual Results- Valuation

External Ecosystem

Sector
Major Subsidiaries/Associates
Key Clients

Products

Products
Product details

Operations

Capacity/ Production
Key Facilities
Key Certifications
Raw materials
Recent News
Paras Healthcare Ltd Peer Comparison – Compare with Others
Read More
  • Past/current
Dr. Agarwal's Health Care Ltd. Estimates – NSE:AGARWALEYE
Read More
  • Past/current
Dr. Agarwal's Health Care Q2 FY27 Earnings Call Details
Read More
  • Past/current
Agarwal's Health Care (NSE:AGARWALEYE): What Does the Amalgamation Scheme Effective Date Mean?
Read More
  • Past/current
Dr Agarwal's Eye Hospital board approves merger with Dr Agarwal's Health Care
Read More
  • Past/current
Dr. Agarwal’s Health Care Board Approves Effectiveness Date and Record Date for Amalgamation with Dr. Agarwal’s Eye Hospital
Read More
  • Past/current
Tax recovery rights preserved despite NCLT approval of amalgamation of Dr. Agarwal’s Eye entities
Read More
  • Past/current
Dr. Agarwal's Health Care Share Price Prediction 2027: Scenario Targets, Valuation and Technical Outlook
Read More
  • Past/current
NCLT sanctions Dr Agarwal's eye hospital merger with health care arm
Read More
  • Past/current
Planning to Buy Hospital Stocks? Jefferies Picks 6 Shares, Gives Target Price
Read More
  • Past/current
Fortis, Max, Apollo, Medanta, Manipal: Buy hospital stocks for 22-46% upside, says Jefferies
Read More
  • Past/current